A Randomized, Double-blind/Open-label, Placebo/Active-controlled, Single/Multiple Dose, Parallel, Phase 1/2a Trial to Evaluate the Safety, Tolerability, PK , PD of YH12852 in Healthy Subjects and Patients With Functional Constipation
Phase of Trial: Phase I/II
Latest Information Update: 31 May 2017
At a glance
- Drugs YH 12852 (Primary) ; Prucalopride
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Yuhan
- 06 Sep 2016 Status changed from recruiting to completed.
- 04 Sep 2015 New trial record
- 03 Sep 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.